GI Innovation, Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by GI Innovation, Inc.
RECRUITINGPhase 1 / Phase 2NCT05824975
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with...
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-102 as a single agent and in combination with conventional...
Sponsor: GI Innovation, Inc.Enrolling: 35811 locations
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6
RECRUITINGPhase 1 / Phase 2NCT07172802
A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or...
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-108, as a single agent, in patients with advanced or metastatic...
Sponsor: GI Innovation, Inc.Enrolling: 763 locations
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Cancer (NSCLC)+3